Heritage Clarifies No Guilty Plea In US Settlement
Executive Summary
Heritage has clarified that its recent settlement deal with the US Department of Justice over price-fixing allegations did not include the company entering a guilty plea.
You may also be interested in...
Apotex, Heritage, Breckenridge US Price-Fixing Settlements Could Top $50m
Direct purchasers of drugs from a trio of generics manufacturers in the US say they will receive payments that are fair and reasonable, under settled agreements that have been put before a judge in Pennsylvania.
Emcure Aims To Split Itself In Half
By the middle of next year, Emcure intends to have demerged its operations in highly developed markets from its activities in India and other emerging markets. The Indian group is seeking private-equity support to grow inorganically in North America and Europe.
Insurance Giant Sues Again On US Pricing
Mylan, Sandoz and Teva, as well as Apotex, Aurobindo, Dr Reddy’s and Lupin, are among the companies accused of price-fixing in the US in an action brought by US insurance giant Humana.